Legal Opinion
In Re Adolor Corp. Securities Litigation
District Court, E.D. Pennsylvania
Decided May 8, 2009No. Civil Action 04-1728PublishedCited by 16 opinions
1Opinion of the Court
MEMORANDUM
SURRICK, District Judge.
Presently before the Court is Defendants’ Motion to Dismiss Plaintiffs’ Amended Class Action Complaint in its Entirety. (Doc. No. 42.) For the following reasons, the Motion will be granted.
I. BACKGROUND
Adolor (“Adolor” or “the Company”) is a bio-pharmaceutical company engaged in the development of pharmaceutical products for the treatment of pain. (Doc. No. 40 ¶ 2 (hereinafter, “Am. Compl.”).) In the early 2000s, Adolor’s lead product was a drug called Entereg, also known as alvimopan, which Adolor developed to treat post-operative ileus (“POI”), a serious…
2Cases cited31 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
26 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Inter-Local Pension Fund Gcc/i v. Rigel Pharmaceuticals, Inc.Court of Appeals for the Ninth Circuit · 2012
- City of Edinburgh Council as A v. Pfizer IncCourt of Appeals for the Third Circuit · 2014
- In re Egalet Corp.District Court, E.D. Pennsylvania · 2018
- In re Urban Outfitters, Inc. Securities LitigationDistrict Court, E.D. Pennsylvania · 2015
- Lerner v. Northwest BiotherapeuticsDistrict Court, D. Maryland · 2017
11 more not listed; retrieve them via the Exa API.